Bharathi Gopalakrishna , PA-C
Physician Assistant • Bellaire, TX
6565 West Loop S, Suite Number 300
Bellaire, TX 774013500
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Bharathi Gopalakrishna is listed in NPPES under Physician Assistant.
-
NPI assigned on May 27, 2015; this date does not establish years in practice.
-
Published CMS data list 1,202 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 142 prescription fills, including refills.
- Amlodipine Besylate — 85 prescription fills, including refills.
- Metoprolol Succinate — 65 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 43 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 85% of clinicians listed under Physician Assistant in Bellaire, TX (2024, 16 clinicians with data). Median for this group: 261. Middle half: 110 to 721.
More Part D prescriptions than 75% of clinicians listed under Physician Assistant in Texas (2024, 4,882 clinicians with data). Median for this group: 261. Middle half: 73 to 938.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 2,769 in 2020 to 1,202 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
6565 West Loop S
Suite Number 300
Bellaire, TX 774013500
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Physician Assistant: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
3,128 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$75,433 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,251.62 across 70 records.
By nature of payment
- Food and Beverage: $1,251.62 across 70 records.
Reporting-company totals (3 largest of 19)
- Novo Nordisk Inc: $294.03 across 15 records.
- ABBVIE INC.: $229.96 across 15 records.
- GlaxoSmithKline, LLC.: $168.23 across 9 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2015
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Bellaire and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Physician Assistant in Bellaire, TX (2024, 16 clinicians with data). Median for this group: 261. Middle half: 110 to 721.
More Part D prescriptions than 75% of clinicians listed under Physician Assistant in Texas (2024, 4,882 clinicians with data). Median for this group: 261. Middle half: 73 to 938.
Part D drug cost
A higher Part D drug cost than 80% of clinicians listed under Physician Assistant in Bellaire, TX (2024, 16 clinicians with data). Median for this group: $6,893. Middle half: $1,347 to $33,823.
A higher Part D drug cost than 70% of clinicians listed under Physician Assistant in Texas (2024, 4,882 clinicians with data). Median for this group: $7,999. Middle half: $749 to $103,240.
23 active clinicians are listed under Physician Assistant with a practice address in Bellaire, TX (11,008 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Bellaire
13% of these 23 clinicians have the CMS telehealth indicator.
60.9% of these 23 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 57% from 2,769 in 2020 to 1,202 in 2024.
- 2020: 2,769
- 2021: 2,874
- 2022: 2,340
- 2023: 1,610
- 2024: 1,202
-
30-day fills
30-day fills decreased 48% from 5,957 in 2020 to 3,128 in 2024.
- 2020: 5,957
- 2021: 6,670
- 2022: 5,594
- 2023: 4,072
- 2024: 3,128
-
Part D drug cost
Part D drug cost decreased 51% from $154,909 in 2020 to $75,433 in 2024.
- 2020: $154,909
- 2021: $177,687
- 2022: $171,837
- 2023: $160,380
- 2024: $75,433
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $377.37 in 2021 to $1,251.62 in 2025.
- 2021: $377.37
- 2022: $1,379.18
- 2023: $1,310.91
- 2024: $1,559.53
- 2025: $1,251.62
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 70 records totaling $1,251.62.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $32.86 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $30.43 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $26.85 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $26.56 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $26.33 |
| Dexcom, Inc. |
Food and Beverage
In-kind items and services
|
Dexcom G6 Transmitter | General | $26.20 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $25.67 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $25.43 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $25.22 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $25.01 |
| Dexcom, Inc. |
Food and Beverage
In-kind items and services
|
Dexcom G6 Transmitter | General | $24.01 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $23.78 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Rybelsus | General | $23.78 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Rybelsus | General | $23.02 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $22.61 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $22.41 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LINZESS | General | $22.27 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $22.01 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
CREON | General | $21.97 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LINZESS | General | $20.91 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $20.86 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $20.51 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $20.48 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $20.24 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $20.16 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 142 | 12,425 | $1,316.14 | 48 |
| Amlodipine Besylate | Amlodipine Besylate | 85 | 6,989 | $578.32 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 65 | 5,624 | $1,129.80 | 23 |
| Losartan Potassium | Losartan Potassium | 57 | 5,068 | $495.61 | 21 |
| Omeprazole | Omeprazole | 49 | 4,170 | $488.05 | 20 |
| Irbesartan | Irbesartan | 46 | 3,960 | $1,147.70 | 14 |
| Levothyroxine Sodium | Levothyroxine Sodium | 42 | 3,780 | $441.47 | 18 |
| Carvedilol | Carvedilol | 41 | 3,606 | $493.14 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 32 | 2,730 | $207.77 | 12 |
| Ezetimibe | Ezetimibe | 32 | 2,880 | $788.42 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 29 | 1,143 | $1,117.24 | — |
| Simvastatin | Simvastatin | 27 | 2,430 | $170.82 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 27 | 2,430 | $438.29 | 11 |
| Azithromycin | Azithromycin | 26 | 128 | $103.84 | 23 |
| Clopidogrel | Clopidogrel Bisulfate | 26 | 2,280 | $469.95 | — |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 26 | 2,340 | $382.36 | — |
| Lisinopril | Lisinopril | 25 | 2,214 | $674.84 | — |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 131 | $131.93 | 18 |
| Ozempic | Semaglutide | 24 | 1,162 | $34,432.10 | 12 |
| Potassium Chloride | Potassium Chloride | 23 | 2,066 | $365.88 | — |
| Allopurinol | Allopurinol | 21 | 1,890 | $234.14 | — |
| Furosemide | Furosemide | 21 | 1,890 | $87.78 | 13 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 21 | 1,815 | $341.13 | — |
| Famotidine | Famotidine | 21 | 1,350 | $367.49 | — |
| Donepezil Hcl | Donepezil Hcl | 20 | 1,080 | $203.27 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-03-04NUCC Taxonomy Code: 363A00000X
A physician assistant is a person who has successfully completed an accredited education program for physician assistant, is licensed by the state and is practicing within the scope of that license. Physician assistants are formally trained to perform many of the routine, time-consuming tasks a physician can do. In some states, they may prescribe medications. They take medical histories, perform physical exams, order lab tests and x-rays, and give inoculations. Most states require that they work under the supervision of a physician.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine
Doctor of Osteopathic Medicine (D.O.)
Internal Medicine
Doctor of Medicine (M.D.)
Family Medicine
Doctor of Medicine (M.D.)
Psychiatry & Neurology - Psychiatry
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 6565 WEST LOOP S STE 300, BELLAIRE, TX 774013505 (Tel: 2814631400)
NPI status registered as active in NPPES database
Registered at 6565 WEST LOOP S, SUITE NUMBER 300, BELLAIRE, TX 774013500 (Tel: 7138507272)
Registered at 4905 SPRUCE ST, BELLAIRE, TX 774014034 (Tel: 7135409862)
Recorded as BHARATHI GOPALAKRISHNA, PA-C
Physician Assistant (license number reported to NPPES: TX PA09711)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Physician Assistants in Bellaire
- Allison Bootin
- Jazz Enriquez, PA-C
- Christopher Hayes, PA-C
- Shelby Bonn, PA-C
- Paige Snikeris, PA-C
- Ruhi Maredia, PA-C
Mailing Address
6565 West Loop S Ste 300
Bellaire, TX 774013505
Phone: 2814631400